Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical

$0.105 -0.010 (-8.70%)

High $0.12	Low $0.10	Trades 57	Turnover $206,557	Volume 1,951,148
30 June 2023 at 4:10pm

Market Cap (2-Sep) $39,037,944 (0th)	Close (30-Jun) $0.105 0 (0%)	Volume (30-Jun) 1,951,148	Shortsold (3-Aug) 875,237 (0.02%) (547th)
52w High $0.040	52w Low $0.009	P/E -	EPS -0.02

Short Interest

ASIC data, 3 Aug 2026

% Shorted

0.02% 0.24

vs 0.26% prior report

Most Shorted Rank

547th

of 696 shorted ASX stocks

Peak Short

0.48%

Dec 2025

Days to Cover

0.1

at 50d avg vol

View full short position history →

	Subject
	RAD RAD Ann: Notification of Release of Shares from Escrow
	1 (current) 2 3
	RAD RAD Ann: Update - Proposed issue of securities
	RAD RAD Ann: Entitlement Offer - Extension of Retail Offer
	RAD RAD Ann: Change in substantial holding - PH
	RAD RAD Ann: Change of Director's Interest Notice - PH
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: Notice Under Section 708A
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RAD RAD Ann: RAD agreement with NorthStar for supply of Actinium-225
	RAD RAD Ann: Entitlement Offer - Letter to Ineligible Shareholders
	RAD RAD Ann: Entitlement Offer - Letter to Option Holders
	RAD RAD Ann: Entitlement Offer - Letter to Eligible Retail Shareholders
	RAD RAD Ann: Appendix 2A
	RAD RAD Ann: Update - Proposed issue of securities
	RAD RAD Ann: Reinstatement to Quotation
	RAD RAD Ann: Supplementary Prospectus
	RAD RAD Ann: Successful Completion of Institutional Entitlement Offer
	RAD RAD Ann: Update - Proposed issue of securities - RAD
	RAD RAD Ann: Entitlement Offer - Presentation
	RAD RAD Ann: Entitlement Offer to raise up to $10 million
	RAD RAD Ann: Prospectus
	RAD RAD Ann: Proposed issue of securities - RAD
	RAD RAD Ann: Investor webinar - Pivalate positive Phase 2 data
	RAD RAD Ann: Presentation - Pivalate achieves positive Phase 2 data
	RAD RAD Ann: Pivalate achieves positive Phase 2 data in brain mets trial
	RAD RAD Article: Radiopharm in $10m rights issue
	RAD RAD Ann: Suspension from Official Quotation
	RAD RAD Ann: Notice of Annual General Meeting/Proxy Form
	RAD RAD Ann: Trading Halt
	RAD RAD Ann: Additional Information - LR4.10.19
	RAD RAD Ann: NATURE releases encouraging data on role of DUNP19 receptors
	RAD RAD Ann: Corporate Governance Statement
	RAD RAD Ann: ESG Report
	RAD RAD Ann: Appendix 4G
	RAD RAD Ann: Corporate Governance Statement
	RAD RAD Ann: Annual Report to shareholders
	RAD RAD Ann: Ga68-Integrin (RAD301) selected for presentation at EANM
	RAD RAD Ann: Pivalate phase II data to be presented at October conference
	RAD RAD Ann: Notification regarding unquoted securities - RAD
	RAD RAD Ann: RAD and SHINE Supply Agreement for Cancer-Fighting Isotope
	RAD RAD Ann: FDA grants pediatric disease designation for DUNP19-revised
	RAD RAD Ann: FDA grants rare pediatric disease designation for DUNP19
	RAD RAD Ann: JV with MD Anderson to develop novel radiopharmaceuticals
	RAD RAD Ann: FDA grants Orphan drug status to RAD DUNP19 for Osteosarcoma
	RAD RAD Ann: Appendix 4E and Preliminary Final Report - unaudited
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Appendix 4E and Preliminary Final Report
	RAD RAD Ann: Notification of Release of Shares from Escrow
	RAD RAD Ann: Strategic agreements with Lantheus and NanoMab

End of Day Prices

Date	Close	Volume	Change
02-Sep	$0.01	3,436,988	0.00 (10.00%)
01-Sep	$0.01	525,334	0.00 (0.00%)
31-Aug	$0.01	5,637,590	+0.00 (11.11%)
28-Aug	$0.01	414,931	0.00 (10.00%)
27-Aug	$0.01	4,855,069	0.00 (0.00%)
26-Aug	$0.01	7,137,112	0.00 (0.00%)
25-Aug	$0.01	617,704	0.00 (9.09%)
24-Aug	$0.01	3,306,588	+0.00 (10.00%)
21-Aug	$0.01	4,959,375	0.00 (0.00%)
20-Aug	$0.01	78,037,359	0.00 (16.67%)
19-Aug	$0.01	6,100,258	0.00 (0.00%)
18-Aug	$0.01	4,917,131	+0.00 (9.09%)
17-Aug	$0.01	3,900,229	0.00 (0.00%)
14-Aug	$0.01	32,607,461	0.00 (8.33%)
13-Aug	$0.01	36,047,834	0.00 (0.00%)
3 up, 5 down, and 7 flat days

Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical

Short Interest

Followers

Prices

Announcements

End of Day Prices

RAD Radiopharm Theranostics Health Care Biotech Cancer Healthcare Medical

Short Interest

Followers

Prices

Announcements

End of Day Prices

Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical